CeriBell Inc reports results for the quarter ended June 30 - Earnings Summary

• CeriBell Inc CBLL.OQ reported a quarterly adjusted loss of 38 cents​​ per share for the quarter ended June 30. The mean expectation of seven analysts for the quarter was for a loss of 39 cents per share. Wall Street expected results to range from -43 cents to -33 cents per share.

• Revenue was $15.92 million​; analysts expected $20.45 million.

• CeriBell Inc's reported EPS for the quarter was a loss of 38 cents​.

• The company reported a quarterly loss of $13.64 million.

• CeriBell Inc shares had fallen by 18.7% this quarter and lost 41.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 5.8% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

• Wall Street's median 12-month price target for CeriBell Inc is $32.00, about 52.4% above its last closing price of $15.23

This summary was machine generated from LSEG data August 5 at 09:43 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)